The Cancer Letter

Inside information on cancer research and drug development

Vol.
28
No.
8
August 26, 2005Aug 26, 2005
Free
DOWNLOAD THE PDF

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

Two-Point Rise In PSA Signals High-Risk Prostate Cancer

High Cervical Cancer Rates Indicate Access Problems

Lifestyle Changes Common After Cancer Diagnosis

Proton Beam Radiation Helps Cancer Patients Retain Vision

Cooperative Group Trials Approved By NCI Are Listed

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account